|
At rebound EC50 38 nM ; and baseline EC50 27 nM ; . Based on these findings, the underlying cause for the observed rebound in these patients is more likely due to lack of adherence to dosing schedules resulting in inconsistent drug exposure rather than viral resistance. Other studies have also identified HBV virologic rebounds to LVD or ADV in the absence of resistance 29, 36 ; . This finding is common in HIV and typically.
Challenge for the test drugs. All patients received a standard premedicationj of meperidine Demerol ; and atropine, and a standard anaesthetic sequence: of thiopentone induction with maintenance fon nitrous-oxide-oxygenrhalothape, succinylcholirie being used for relaxation as required. The test drugs were coded in batches in identical vials, and the appropriate dose of the selected drug was givenj by intramuscular injection i: o each patient included in the trial as she arrived in the; recovery room. The selection of drug was dictated by reference to a random llocation sheet for each operation, and to body weight, by giving 0.04 jc.c. the amount of drug was made proportio of test solution per pound of body weight. Perphenazine was diluted to JL.25 mg. e.c.? tfimethobenzamide to 100 mg. c.c. and thiethylperazin to 5 mg. ic.c. using sterile 5 per cent dextrose water, which was also used for the placebo. The 140-pound patient, for example. thus received f mg. of perphenazine, 560 mg. of trimethobenzamide or 28 mg. of thiethylperazine. All patients were observed for two hours in the recovery room, and incidents of nausea and vomiting were charted at 15-minute intervals using a score system. , A complaint of nausea was scored as one observed retching or gagging without each episode of liquid emesis scored liquid emesis was scored as two, three. Patients were visited between 24 nd 48 hours after operation, and the incidents nausea and vomiting reqorded on the patient's chart were correlated with thd patient's observations, and' scored in the same way. Scores rnade in the firjt; 15 minutes were disregarded, si nee it was felt tha the test agent had not begun to act during this period.
According to the agency, the oral capsule and injectable forms of trimethobenzamide are not affected by this action.
This command allows a user to change his or her own password. The password cannot be null. It will be echoed as clear text as the message is parsed only after the complete message is entered and terminated. Notes.
Results: Mean operative time was 77.3 minutes. Mean warm ischemia time was13.3 6.7 minutes. Estimated blood loss was 42.1 39.7 cc. Mean weight of resected specimen was 12.3 3.2 g. All 8 animals demonstrated immediate hemostasis on hilar clamp release. Pyelography failed to demonstrate any collecting system leakage, and closure and healing was confirmed by in all. 2 pigs were euthanized for causes unrelated to procedures 4 days prior study end. Conclusion: Sutureless repair of laparoscopic heminephrectomy defects is safe and efficacious in physiological and chronic obstructive conditions in swine. The procedure is reproducible and resection renorrhaphy was completed on average in less than 14 minutes warm ischemia time.
Generic Trimethobenzamide
Enrollment Policy for Pharmacy Providers To participate in the Alabama Medicaid Program, Pharmacy providers must meet the following requirements: Operate under a permit or license to dispense drugs as issued by the Alabama State Board of Pharmacy or appropriate authority in the State where the service is rendered. Agree to abide by the rules and regulations of third party billing procedures. Refer to Section 3.3.6, Third Party Liability, for more information. Maintain records, including prescriptions, to fully disclose the extent of services rendered. Pharmacies should maintain records, such as purchase invoices and recipient signature logs, within the state of Alabama. At a minimum, prescription files and invoices must be available for examination and trimethoprim.
9 0aircraft and it '&pears; ' that.: , the -&Oraft: -~may not meet the applicable certification * item 'bf.''Part : 25. of the Federal '8 Aviation Regulations ' FARF. ' ' '.
Medications Cheap Drugs
Feedback join now sign in my healthline free newsletters home health channels diseases & conditions drugs symptoms videos health experts tools marketplace drug notebook print email generic name: trimethobenzamide view all brands trimethobenzamide hydrochloride , tigan , benzacot , ticon an anticholinergic antiemetic - treats nausea vomiting basic info top questions clinical info interactions licensed from trimethobenzamide page: 1 2 next try meth oh ben za mide ; uses dosage and administration cautions drug interactions pharmacokinetics stability actions advice to patients preparations top rx drugs albuterol amoxicillin ampicillin atenolol azithromycin benzocaine cephalexin clindamycin cloxacillin desonide doxycycline furosemide hydrochlorothiazide hyoscyamine ibuprofen levothyroxine lisinopril metformin metoprolol multivitamins nortriptyline phendimetrazine ranitidine rifampin simvastatin advertisement uses nausea and vomiting control of nausea and vomiting , including treatment of postoperative nausea and vomiting and trimipramine.
EDISON COMMUNITY COLLEGE ASSOCIATE DEGREE NURSING PROGRAM NUR 165S Campus lab guide 1 Focus: Apply the nursing process of assessment, planning, implementation and evaluation for clients needing EKG monitoring. Review electro-cardiogram monitoring. OUTCOMES CONTENT LEARNING ACTIVITIES the completion of the laboratory Discussion of skill considerations. experience the student will be able to: Practice of skills. Returns demonstrate the following selected skills. A. Identify the essentials of rhythm interpretation. A. Cardiac assessment and emergency intervention. 1. Interpret regular sinus rhythm and lethal cardiac rhythm on a lead II rhythm strip. Recognize and demonstrate: 1. PQRST complex 2. Regular sinus rhythm 3. PVC's, PAC's, Atrial Flutter, Atrial Fibrillation, Supraventricular Tachycardia, Heart blocks. 4. VT, V. Fib, Asystole Smith & Duell: Ch. 27, Unit 3 pages 951-961. Cohn: Flip and See ECG.
Trimethobenzamide tablets
Pennsylvania Department of Health - 2003-2004 Annual C.U.R.E. Report - Page 1473 and triptorelin.
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NA, not applicable. SI conversion factors: To convert mg dL of triglycerides to mmol L, multiply by 0.0113; mg dL of HDL-C, LDL-C, and total cholesterol to mmol L, multiply by 0.0259. * Statistically significant P .05 ; based on stratum-adjusted difference in treatment groups. Calculated as weight in kilograms divided by the square of height in meters.
FIGURE 1. Time sequence and blood pressure effects of catecholamine depletion, injection of the vasopressin antagonist, and infusion of the angiotensin converting enzyme inhibitor in anephric rats and rats with intact kidneys and trizivir.
LARGE ACCUMULATION: yet another group of material from the Norm De Pomeroy collection. Six large boxes of assorted material; manly railway oriented but covering the topic from every conceivable angle. Strong in: correspondence from former VR Head Office files from virtually every decade of the 20th Century "S" notices covering Victorian special train movements; magazines & assorted literature from various Australian preservation groups; rail union material; numerous blueprints. Months of sorting fun for the purchaser! 1, 000s ; . 0 - 0 VR: DYNOMETER TESTS for various 4-6-0 A2 steam locos., presented as extremely long rolls of paper 65cm wide and many metres long ; , recording various 70km 150km return journeys Melbourne-Geelong Bendigo, to test loco. braking and coal burning efficiency. The rolls show tests made between 5 3 1934 and 8 11 1940, including a double-headed test using A2 996 & A2 995. An important part of the saga of Victorian steam! 8 ; . 0 - 0 VR: DYNOMETER TEST 392 on S301, presented as an extremely long roll of paper 65cm wide and many metres long ; , recording the 300km journey Melbourne-Albury, on 26 2 1935, using Maitland coal and with a load of 470 tons. Presumed to be an efficiency test to assess the S class steam locomotives' suitability for streamlining. A fantastic opportunity to acquire a rare and important piece of Australian Railway history! . 0 - 0 VR: DYNOMETER TEST 393 on S301, presented as an extremely long roll of paper 65cm wide and many metres long ; , recording the 300km journey Albury-Melbourne, on 26 2 1935, using Maitland coal and with a load of 470 tons. Presumed to be an efficiency test to assess the S class steam locomotives' suitability for streamlining. A rarely offered research item! . 0 - 0 VR: DYNOMETER TEST 394 on S302, presented as an extremely long roll of paper 65cm wide and many metres long ; , recording the 200km journey Melbourne-Benalla, on 26 2 1935, using Maitland coal and with a load of 577 tons. Presumed to be an efficiency test to assess the S class steam locomotives' suitability for streamlining. 0 - 0 VR: DYNOMETER TEST 398 on S302, presented as an extremely long roll of paper 65cm wide and many metres long ; , recording the 200km journey Melbourne-Benalla, on 6 3 1935, using Maitland coal and with a load of 560 tons. Presumed to be an efficiency test to assess the S class steam locomotives' suitability for streamlining 0 - 0 VR: DYNOMETER TEST 395 on S302, presented as an extremely long roll of paper 65cm wide and many metres long ; , recording the 200km journey Benalla-Melbourne, on 26 2 1935, using Maitland coal and with a load of 805 tons. Presumed to be an efficiency test to assess the S class steam locomotives' suitability for streamlining 0 - 0 VR: DYNOMETER TEST 399 on S302, presented as an extremely long roll of paper 65cm wide and many metres long ; , recording the 200km journey Benalla-Melbourne, on 6 3 1935, using Maitland coal and with a load of 836 tons. Presumed to be an efficiency test to assess the S class steam locomotives' suitability for streamlining 0 - 0 VR: DYNOMETER TESTS for 2-8-0 steam locos. C2, C9, C18 & C19, presented as extremely long rolls of paper 65cm wide and many metres long ; , recording various 150km return journeys Melbourne-Bendigo, to test loco. braking and coal burning efficiency. The rolls shows a test made on 21 3 1935 along with other similarly dated tests. These one-off rolls record important tests during this period! 6 ; . 0 - 0.
Of 7 a day for the children in this pilot. 16 See Appendix XI ; DFPS discontinued the pilot in August 2002. A study done by the University of Texas, School of Social Work determined that the pilot had successful outcomes and helped secure foster care placements for these children, who may have otherwise had no placement options. DFPS stated, "that the study also provided recommendations for future implementation of such a program however, due to funding limitations the project was not continued. DFPS has continued efforts to place children at Intense levels and all other levels ; in the least restrictive settings." In fiscal 2004, psychiatric hospitalization of foster children cost Texas Medicaid a range of rates depending on Medicaid's contract with each psychiatric hospital. Some psychiatric hospitals reported rates from 5 to 0 a day.23 In the same year, the cost of an intense residential treatment center care in Texas was 2 a day, less than half that of a psychiatric hospital. The daily rate for the Texas Exceptional Care pilot was 7 a day, still only about half the cost of psychiatric hospitalization. To the contrary DFPS places very emotionally disturbed foster children into restrictive psychiatric hospitals at a rate of more than 0 per day that is paid for out of HHSC's budget, rather than use a less restrictive residential treatment center approach at 7 per day, which is paid from the DFPS budget. highly trained and supervised parents a Partial Hospital Program a structured daytime program that includes school, therapy and medication management outpatient therapy in which the child lives at home and attends weekly individual or family therapy behavioral management services in which a worker helps the parents and child learn and practice new skills and case management services in which a case manager helps parents locate and obtain food and housing assistance, school services, child care, therapy and other necessities ; .17 and troleandomycin.
Luks K. Anything new in the treatment of gastro-oesophageal reflux disease. Folia Gastroenterol Hepatol 2006; 4 1 ; : 11 26. Abstract. Gastro-oesophageal reflux disease is a malady caused by pathological gastro-oesophageal reflux. The most frequent manifestation of the disease is reflux oesophagitis. The origin of the reflux disease is determined by the aggressive and protective factors balance. One of the aggressive factors is the gastro-oesophageal reflux in which a crucial role is played by hydrochloric acid. On the other hand, the protective factors include antireflux barriers, luminal clearance and tissue resistance. At present, the transient relaxation of the lower oesophageal sphincter is deemed the major cause of refluxate penetration into the oesophagus. Treatment is limited to reducing damage caused by the gastro-oesophageal reflux, specifically by hydrochloric acid and pepsin. Traditional therapy uses mostly anti-secretion drugs, the most effective are proton pump inhibitors. In the indicated cases prokinetics are administered. It seems that reduction of transient relaxations of the lower oesophageal sphincter by GABA receptors stimulation is promising. Endoscopic treatment has been tested, surgical therapy laparoscopic fundoplication is already established. Key words: gastro-oesophageal reflux disease, reflux oesophagitis, proton pump inhibitors, prokinetics Luks K. Je nco novho v lcb refluxn choroby jcnu? Folia Gastroenterol Hepatol 2006; 4 1 ; : 11 26. Souhrn. Refluxn choroba jcnu je onemocnn zpsoben patologickm gastroezofagelnm refluxem. Nejcastjs manifestac je refluxn ezofagitida. Vznik refluxn choroby je urcovn rovnovhou mezi faktory agresivnmi a defenzivnmi. K faktorm agresivnm je azen gastroezofageln reflux, u kterho hraje hlavn roli koncentrace kyseliny chlorovodkov. Z ochrannch faktor psob antirefluxn bariry, luminln ocista a tkov rezistence. V soucasn dob jsou za hlavn pcinu moznosti vnikn refluxtu do jcnu povazovny pechodn relaxace dolnho jcnovho svrace. Lcba je zamena na redukci poskozen vznikajcho gastroezofagelnm refluxem, zejmna vlivem kyseliny a pepsinu. V lcb konzervativn jsou uzvny zejmna antisekrecn lky, nejcinnjs jsou inhibitory protonov pumpy. V indikovanch ppadech jsou podvna prokinetika. Zd se, ze budoucnost je v omezen pechodnch relaxac dolnho jcnovho svrace pomoc stimulac GABA receptor. Je zkousena lcba endoskopick. Zavedena je lcba chirurgick laparoskopick fundoplikace. Klcov slova: refluxn choroba jcnu, refluxn ezofagitida, inhibitory protonov pumpy, prokinetika 11!
Prednisolone hydramine diphenhydramine hydrochloride hydrobexan injection hydroxocobalamin hydropres 25 mg tablet hydrochlorothiazide and reserpine hydroxacen hydroxyzine hyper-tet tetanus immune globulin human ; inocor inamrinone amrinone ; intal inhalation capsule cromolyn sodium intercept nonoxynol 9 iodo-niacin tablet potassium iodide and niacinamide hydroiodide iophen iodinated glycerol iophen-c iodinated glycerol and codeine iophen-dm iodinated glycerol and dextromethorphan all products ; iophylline iodinated glycerol and theophylline iotuss iodinated glycerol and codeine iotuss-dm iodinated glycerol and dextromethorphan all products ; iso-bid isosorbide dinitrate isopto p-es pilocarpine and physostigmine isovex ethaverine hydrochloride isuprel glossets isoproterenol kaopectate children's tablet attapulgite kato powder potassium chloride keflin cephalothin sodium kestrin injection estrone koate-hs injection antihemophilic factor human ; koate-ht injection antihemophilic factor human ; kolyum powder potassium chloride and potassium gluconate konyne-ht injection factor ix complex human ; kwell lindane lamprene 100 mg clofazimine laniazid tablet isoniazid lasan topical anthralin lasan hp-1 topical anthralin ledercillin vk penicillin v potassium libritabs 5 mg chlordiazepoxide listerex scrub salicylic acid lorcet hydrocodone and acetaminophen lorelco probucol malatal hyoscyamine, atropine, scopolamine, and phenobarbital malotuss syrup guaifenesin mandelamine tablet methenamine mantadil cream chlorcyclizine marezine injection cyclizine hydrochloride marplan isocarboxazid max-caro beta-carotene meclomen meclofenamate sodium medihaler-epi epinephrine medihaler ergotamine ergotamine medrapred prednisolone and atropine medrol acetate topical methylprednisolone melfiat tablet phendimetrazine tartrate meprospan meprobamate metaprel aerosol metaproterenol sulfate metaprel inhalation solution metaproterenol sulfate metaprel tablet metaproterenol sulfate metizol tablet metronidazole metopirone tablet metyrapone tartrate metra phendimetrazine tartrate miflex tablet chlorzoxazone and acetaminophen milprem meprobamate uday • reply feb 14, 2006 1: two-week break, then repeat cycle fle fluorouracil 450 mg m2 for 5 days, then, after a pause of 4 weeks, 450 mg m2, weekly for 48 weeks levamisole 50 mg tid for 3 days, repeated every 2 weeks for 1 year fmv fluorouracil 10 mg kg day, days 1-5 methyl-ccnu 175 mg m2, day 1 vincristine 1 mg m2 max: 2mg ; , day 1 repeat cycle every 35 days fu lv fluorouracil 370-400 mg m2 day, days 1-5 leucovorin calcium 200 mg m2 day, commence infusion 15 min prior to fluorouracil infusion, days 1-5 repeat cycle every 21 days or fluorouracil 1000 mg m2 day by continuous infusion, days 1-4 leucovorin calcium 200 mg m2 day, days 1-4 repeat cycle every 28 days weekly 5fu lv fluorouracil 600 mg m2 over 1h given after leucovorin, repeat weekly x 6 then 2-week rest period 1 cycle, days 1, 8, 15, leucovorin calcium 500 mg m2 over 2 h, days 1, 8, 15, repeat cycle every 56 days 5fu ldlf fluorouracil 425 mg m2 day, days 1-5 leucovorin calcium 20-25 mg m2 day, days 1-5 repeat cycle every 28 days single-agent regimens 5-fu 1000 mg m2 day, continuous infusion, days 1-5 repeat cycle every 21-28 days irinotecan 125 mg m2 over 90minutes every 7 days for 4 cycles or 350 mg m2 over 30 minutes repeat cycle every 21 days brand name generic name achromycin parenteral tetracycline achromycin v capsule tetracycline achromycin v oral suspension tetracycline acth-40 corticotropin actidil triprolidine actifed syrup triprolidine and pseudoephedrine actifed with codeine triprolidine, pseudoephedrine, and codeine actinex masoprocol adipost phendimetrazine tartrate adphen phendimetrazine tartrate adrin nylidrin hydrochloride aerolate oral solution theophylline aerosporin injection polymyxin b agoral plain mineral oil akoline tablet vitamin ak-zol acetazolamide ala-tet tetracycline amen medroxyprogesterone acetate amin-aid amino acid amonidrin tablet guaifenesin anacin-3 all products ; acetaminophen anaids tablet alginic acid and sodium bicarbonate anergan 25 injection promethazine hydrochloride antilirium physostigmine antinea cream benzoic acid and salicylic acid antivert chewable tablet meclizine hydrochloride antrocol capsule & tablet atropine and belladonna apomorphine apomorphine now available as an orphan drug only ; apresazide hydralazine and hydrochlorothiazide arcotinic tablet iron and liver combination argyrol silver protein, mild arlidin nylidrin all products ; arrestin trimethobenzamide arthritis foundation ibuprofen ibuprofen arthritis foundation nighttime acetaminophen and diphenhydramine arthritis foundation pain reliever, aspirin free acetaminophen arthritis strength bufferin aspirin buffered ; articulose-50 injection prednisolone asbron-g elixir theophylline and guaifenesin asbron-g tablet theophylline and guaifenesin asproject sodium thiosalicylate atabrine tablet quinacrine hydrochloride atropine soluble tablet atropine soluble tablet aureomycin chlortetracycline axotal butalbital compound and aspirin azlin injection azlocillin azo gantanol sulfamethoxazole and phenazopyridine azo gantrisin sulfisoxazole and phenazopyridine azulfidine suspension sulfasalazine b-a-c butalbital compound with aspirin bactocill oxacillin bancap butalbital compound with acetaminophen banesin acetaminophen bantron lobeline all products ; baypress nitrendipine becomject-100 vitamin b complex beesix pyridoxine hydrochloride bellafoline levorotatory alkaloids of belladonna all products ; bemote dicyclomine bena-d diphenhydramine benadryl 50 mg capsule diphenhydramine hydrochloride benadryl cold flu acetaminophen, diphenhydramine, and pseudoephedrine benahist injection diphenhydramine hydrochloride benoject diphenhydramine hydrochloride betapen-vk penicillin v potassium beta-val ointment betamethasone betoptic betaxolol biamine injection thiamine hydrochloride bilezyme tablet pancrelipase biomox amoxicillin biphetamine amphetamine and dextroamphetamine blanex capsule chloroxazone and acetaminophen bretylol bretylium bronkephrine ethylnorepinephrine hydrochloride buffered, tri-buffered aspirin bufferin arthritis strength aspirin bufferin extra strength aspirin buf-puf acne cleansing bar salicylic acid butace butalbital compound caladryl spray diphenhydramine and calamine calciparine injection heparin calcium camalox suspension & tablet aluminum hydroxide, calcium carbonate, and magnesium hydroxide cantharone cantharidin cantharone plus cantharidin caroid cascara sagrada and phenolphthalein catarase 1: 5000 chymotrypsin all products ; cedilanid-d injection deslanoside cenocort a-40 triamcinolone cenocort forte triamcinolone centrax capsule & tablet prazepam cerespan papaverine hydrochloride cetane ascorbic acid chenix tablet chenodiol chlorgest-hd elixir chlorpheniramine, phenylephrine, and hydrocodone chlorofon-a tablet chlorzoxazone chloromycetin cream chloramphenicol chloromycetin kapseals chloramphenicol chloromycetin ophthalmic chloramphenicol chloromycetin otic chloramphenicol chloromycetin palmitate oral suspension chloramphenicol chloroserpine reserpine and hydrochlorothiazide chlortab chlorpheniramine maleate choledyl oxtriphylline chymex bentiromide all products ; cipralan cifenline cithalith-s syrup lithium citrate citro-nesia solution magnesium citrate clistin tablet carbinoxamine maleate clorpactin xcb powder oxychlorosene sodium cobalasine injection adenosine phosphate codimal-a injection brompheniramine maleate codimal expectorant guaifenesin and phenylpropanolamine coly-mycin s oral colistin sulfate constant-t tablet theophylline control-l pyrethrins cortaid ointment hydrocortisone cortrophin-zinc corticotropin crysticillin 300 penicillin g procaine crysticillin 600 penicillin g procaine crystodigin 05 mg & 15 mg tablet digitoxin cyclospasmol cyclandelate all products ; cycrin 10 mg tablet medroxyprogesterone acetate dalgan dezocine d-amp ampicillin danex shampoo pyrithione zinc darbid tablet isopropamide iodide all products ; daricon oxyphencyclimine all products ; darvon 32 mg capsule propoxyphene hydrochloride darvon-n oral suspension propoxyphene napsylate datril extra strength acetaminophen decadron phosphate ophthalmic ointment dexamethasone decadron 25 mg and 6 mg tablets dexamethasone decaspray dexamethasone dehist brompheniramine maleate deltalin capsule ergocalciferol depo-provera 100 mg ml medroxyprogesterone deprol meprobamate and benactyzine hydrochloride dermoxyl gel benzoyl peroxide despec liquid guaifenesin, phenylpropanolamine, and phenylephrine dexacen-4 dexamethasone dexacen la-8 dexamethasone dexedrine elixir dextroamphetamine sulfate dialose capsule docusate sodium diaparene cradol methylbenzethonium dilantin-30 pediatric suspension phenytoin dilantin with phenobarbital phenytoin with phenobarbital dilaudid 1 mg & 3 mg tablet hydromorphone hydrochloride dimetane brompheniramine maleate dispos-a-med isoproterenol isoproterenol diupress chlorothiazide and reserpine dizymes tablet pancreatin dommanate injection dimenhydrinate donphen tablet hyoscyamine, atropine, scopolamine, and phenobarbital dopastat injection dopamine hydrochloride doriden tablet glutethimide doxinate capsule docusate sodium dramamine injection dimenhydrinate dramocen dimenhydrinate dramoject dimenhydramine d-s-s plus docusate and casanthranol duo-medihaler isoproterenol and phenylephrine duracid aluminum hydroxide, magnesium carbonate, and calcium carbonate duract bromfenac all products ; dyflex-400 tablet dyphylline elase ointment fibrinolysin and desoxyribonuclease all products ; elase-chloromycetin ointment fibrinolysin and desoxyribonuclease eldepryl tablet selegiline eldoquin lotion hydroquinone elixophyllin sr theophylline e-lor tablet propoxyphene and acetaminophen emete-con injection benzquinamide emetine hydrochloride emetine hydrochloride endep 25 mg, 50 mg, 100 mg amitriptyline hydrochloride enduron 5 mg tablet methyclothiazide enkaid encainide enovid mestranol and norethynodrel t and trovafloxacin.
Small pieces of tissue were removed from the tip of the apical, cardiac, and diaphragmatic lobes of each half of the lung; and the bronchi were flushed with tap water. The effluent was examined as above. The air tracts of both the flushed lung and the tissue pieces were opened with scissors and examined. All lungworms were removed and counted. In August 1990, 18 hares were trapped on a 5.4 ha grid. Eight were examined for worm numbers present at the start of the experiment, and 10 were treated with a single dose of ivermectin. The 10 treated hares were kept in five pens 1.8 m X 4.6 m X 1.0 m ; , with one male and either one or two females in each pen. One treated hare escaped. The pens were constructed from chicken wire and the base of each wall was buried 15 cm into the ground. The hares were supplied ad libitum with rabbit chow Shur-Gain, Edmonton, Alberta, Canada ; once a day and with willow Salix glauca ; , and bog birch Betula glandulosa ; , in the morning and evening of each day. Infection from transmis and trimethobenzamide.
|